Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02799212
What this trial is testing

Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Hospices Civils de Lyon 179
Large-scale testing (Phase 3)UnknownNCT04168944
What this trial is testing

Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
RenJi Hospital 108
Testing effectiveness (Phase 2)Looking for participantsNCT07145801
What this trial is testing

Y-90 Treatment Response Using Transarterial Radioembolization

Who this might be right for
HCCHepatocellular CarcinomaLiver Cancer+3 more
Thomas Jefferson University 30
Early research (Phase 1)UnknownNCT04612504
What this trial is testing

SynOV1.1 Intratumoral Injection Study

Who this might be right for
Hepatocellular Carcinoma
Beijing Syngentech Co., Ltd. 15
Early research (Phase 1)Looking for participantsNCT06515314
What this trial is testing

HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors

Who this might be right for
Hepatic Cell Carcinoma
Shanghai Ruiliyuan Biotechnology Co., Ltd. 12
Testing effectiveness (Phase 2)Looking for participantsNCT06467799
What this trial is testing

Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC

Who this might be right for
Hepatocellular CarcinomaBeyond Milan Criteria
Sun Yat-sen University 39
Not applicableStudy completedNCT03476421
What this trial is testing

R1vascular Hepatectomy for HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Humanitas Clinical and Research Center 327
Not applicableStudy completedNCT05495529
What this trial is testing

Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors

Who this might be right for
Radiology, InterventionalLiver NeoplasmCarcinoma, Hepatocellular (RENI)+4 more
Centre Hospitalier Universitaire de Nice 61
Not applicableStudy completedNCT03782207
What this trial is testing

A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

Who this might be right for
Urothelial CarcinomaNon-Small Cell Lung CancerSmall Cell Lung Cancer+1 more
Hoffmann-La Roche 2,756
Not applicableStudy completedNCT06358001
What this trial is testing

EchoTip AcuCore Post-Market Clinical Study

Who this might be right for
AdenocarcinomaNeuroendocrine TumorsHepatocellular Carcinoma+5 more
Cook Research Incorporated 183
Not applicableStudy completedNCT00824707
What this trial is testing

Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer

Who this might be right for
Primary Liver Cancer
Eastern Hepatobiliary Surgery Hospital 200
Post-approval studies (Phase 4)Not Yet RecruitingNCT06786429
What this trial is testing

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

Who this might be right for
Hepatitis BHuman Papilloma VirusMental Health Issue+3 more
Eunice Dube 2,140
Testing effectiveness (Phase 2)Ended earlyNCT05448677
What this trial is testing

Ezurpimtrostat Autophagy Inhibitor in Association With Atezolizumab-Bevacizumab in First Line Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Grenoble 3
Post-approval studies (Phase 4)UnknownNCT02308319
What this trial is testing

Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal Load

Who this might be right for
Carcinoma, Hepatocellular
Samsung Medical Center 124
Not applicableStudy completedNCT02173119
What this trial is testing

Can Quantitative MRI After cTACE Help Predict Survival ?

Who this might be right for
Hepatocellular Carcinoma (HCC)
Medical College of Wisconsin 23
Not applicableStudy completedNCT00178867
What this trial is testing

A National Registry of Patients With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Vanderbilt University 150
Testing effectiveness (Phase 2)Looking for participantsNCT06015022
What this trial is testing

EGCG for Hepatocellular Carcinoma Chemoprevention

Who this might be right for
Cirrhosis, Liver
University of Texas Southwestern Medical Center 60
Not applicableStudy completedNCT04966195
What this trial is testing

Stereotactic Body Radiotherapy Based Treatment for Hepatocellular Carcinoma With Extensive Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma Non-resectablePortal Vein Tumor ThrombosisStereotactic Body Radiotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Not applicableActive Not RecruitingNCT07048665
What this trial is testing

Effectiveness of Trans-Arterial Chemo Embolization for Hepatocellular Carcinoma on Follow-Up CT Triphasic Liver

Who this might be right for
Hepatocellular Carcinoma
Superior University 60
Large-scale testing (Phase 3)WithdrawnNCT01318200
What this trial is testing

Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC)

Who this might be right for
Recurrent Hepatocellular Carcinoma
Accuray Incorporated
Next Page